Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06351202
Other study ID # RBGP 2023 COLNE
Secondary ID 2023-A02256-39
Status Recruiting
Phase N/A
First received
Last updated
Start date May 16, 2024
Est. completion date June 2026

Study information

Verified date January 2024
Source University Hospital, Clermont-Ferrand
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Every year in France, 60,000 children are born prematurely (before 37 weeks of amenorrhea - WA), and present an immaturity of their various systems, in particular the digestive system. This can result in feeding intolerance, expressed by abdominal distension, regurgitation, irregular transit and abdominal discomfort. It can influence the length of hospitalization and lead to necrotising enterocolitis, a major complication. At the Clermont-Ferrand University Hospital Center, abdominal massages have been performed by physiotherapist for several years in order to improve the state of the digestive system of preterm infants. The indication for abdominal massages are very dependent on the caregivers in charge of the newborns because the evaluation of feeding intolerance remains subjective. In this context, the investigators carried out a first study to validate a scale that they created (ECAP scale : Clinical Assessment Scale for Abdominal state of Preterm infant) to assess in a rapid, reliable and reproductible manner the abdominal state of preterm infant - data currently being published). This scale can pose the indications for abdominal massage more objectively. The hypothesis is that abdominal massage improves feeding tolerance (decrease ECAP score), allows faster weight gain and reaching the full ration and therefore reduces the length of hospitalization of preterm infants. The aim of the study is to assess the effectiveness of abdominal massage, over a period of 14 days, on the feeding tolerance of preterm infants (under 34 weeks of amenorrhea), defined by the achievement and maintenance of an ECAP score less than 4 during 3 days.


Description:

This is a single-blind, randomized controlled study. The children will be recruited in the Neonatal Intensive Care Units of the investigation center, by the nursing staff carrying out the ECAP assessment (physiotherapists, nurses, doctors). An information note will be presented and explained by an element of the medical or paramedical staff to the parents. After a 24 hours reflexion period and answer to any questions they may have, written and informed consent will be requested from both parents for their child's participation in this study. After obtaining the signed consents, the randomization will follow. In the first group, preterm infants with feeding intolerance will not be massed. In the second group, at least 10 abdominal massages will be performed by a physiotherapist trained in this technique over a period of 14 days, at the rate of one massage per day. Each day, the ECAP assessment will be performed at t0min (just before performing an abdominal massage in the massed group) and at t10min (just after performing the massage). The investigators estimate that an abdominal massage for premature babies lasts 10 minutes. The abdominal massage techniques will be adapted according to the term of the child.


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date June 2026
Est. primary completion date February 2026
Accepts healthy volunteers No
Gender All
Age group 3 Days to 60 Days
Eligibility Inclusion Criteria: - Newborn, premature, less than 34 Weeks of Amennorhea - at least 3 days of life - hospitalized in neonatal intensive care units - with feeding intolerance demonstrated by an ECAP (Clinical Abdominal Assessement scale for preterms) score equal to or greater than 4/20 - whose holders of parental authority are able to give free and informed consent to participate in this study. Exclusion Criteria: - premature newborns with a congenital pathology such as malformation, genetic or chromosomal abnormality - newborns whose holders of parental authority are protected by law (under guardianship, curatorship, placed under judicial safeguard) or aged under 18 - rejection of participation by parents - newborns with a contraindication to abdominal massage (fever, major hemodynamic instability)

Study Design


Intervention

Other:
Abdominal massage
An abdominal massage for premature babies lasts 10 minutes. Our abdominal massage techniques is described in our protocole and will be adapted according to the term of the child.

Locations

Country Name City State
France CHU clermont-ferrand Clermont-Ferrand

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical Abdominal assessment scale for Preterm infants score (ECAP score) score between 0 and 20 twice day during 14 days
Secondary Variation of the ECAP score (Clinical Abdominal assessement scale for preterms score) between t0 minute and t10 minutes score between 0 and 20 up to 14 days
Secondary Weight gain of preterm infants with feeding intolerance Daily weight of preterm infants, in z-score up to 28 days
Secondary Duration to reach the full ration Number of days needed to reach the full ration (120mL/kg/day) up to 28 days
Secondary Duration of hospitalization in level 3 Total number of days of hospitalization in level 3 up to 3 months
Secondary 6-hour fasting windows Number of 6-hour fasting windows up to 28 days
Secondary Incidence of occurrence of necrotizing enterocolitis number of necrotizing enterocolitis up to 28 days
Secondary Evolution of digestive tolerance over time Raw ECAP value at t10 minutes over time up to 28 days
See also
  Status Clinical Trial Phase
Recruiting NCT05066139 - Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G) N/A
Recruiting NCT04475952 - Early Diagnosis of Upper Digestive Tract Disease
Completed NCT05064163 - SROI Project on the Surgical Waiting List Management System
Completed NCT03559543 - Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma Phase 2
Completed NCT03549494 - Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction Phase 2
Completed NCT03723447 - Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®) Phase 4
Enrolling by invitation NCT01483248 - Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver Cirrhosis Phase 1/Phase 2
Completed NCT03008460 - Efficacy, Safety and Tolerability of Eziclen®/Izinova® Versus Klean-prep® on Bowel Cleansing in Adolescents Undergoing Colonoscopy Phase 3
Active, not recruiting NCT05253859 - CFTR Modulators and Gastrointestinal Complications
Not yet recruiting NCT05636657 - Comparative Study of Intestinal Color Ultrasound and Capsule Endoscopy in Monitoring Crohn's Disease
Completed NCT05160077 - Optoacoustic Characterization of Postprandial Intestinal Blood Flow N/A
Recruiting NCT05401058 - Low-dose Droperidol for Prevention of Postoperative Delirium in Elderly Patients After Non-cardiac Surgery N/A
Completed NCT06283732 - A Clinical Study to Assess the Effect of a Supplement on Digestive Health, Overall Well-being, and Participant Experience. N/A
Not yet recruiting NCT06271538 - Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome Phase 4
Terminated NCT03594331 - Gastric Gluten-Degradation Activity of PvP001 Phase 1
Not yet recruiting NCT05405842 - Transauricular Vagal Nerve Stimulation; Functional Dyspepsia and Gastroparesis N/A
Completed NCT02785783 - Endorings™ Assisted Colonoscopy Versus Standard Colonoscopy for Polyp Detection N/A
Completed NCT00072943 - A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's Disease Phase 2
Completed NCT03037385 - Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors Phase 1/Phase 2
Completed NCT05827679 - Creation and Validation of a Clinical Evaluation Scale for Abdominal Condition of the Premature (ECAP)